Xu Y, Chen M, Gao X, Liu X, et al. Efficacy and safety of sunvozertinib monotherapy as first-line treatment in NSCLC patients with EGFR exon 20 insertion mutations: A phase 2, single-center trial. Cancer Lett 2025;630:217904.
PMID: 40618881